Patent application number | Description | Published |
20130055466 | Methods and Compositions for Watermelon Firmness - The invention provides for unique watermelon plants with an ultra-firm flesh phenotype and their progeny. Such plants may comprise an introgressed QTL associated with an ultra-firm flesh phenotype. In certain aspects, compositions, including distinct polymorphic molecular markers, and methods for producing, breeding, identifying, selecting, and the like of plants or germplasm with an ultra-firm flesh phenotype are provided. | 02-28-2013 |
20130298278 | METHODS AND COMPOSITIONS FOR PRODUCING PLANTS WITH ELEVATED BRIX - The invention provides compositions and methods relating to the production of | 11-07-2013 |
20140041078 | METHODS AND COMPOSITIONS FOR PRODUCING WATERMELON PLANTS WITH SELECTED SEED SIZES - The present disclosure provides for unique watermelon plants with a desired seed size phenotype and their progeny. Such plants may comprise an introgressed QTL associated with a desired seed size phenotype. In certain aspects, compositions, including distinct polymorphic molecular markers, and methods for producing, breeding, identifying, selecting, and the like of plants or germplasm with a desired seed size phenotype are provided. | 02-06-2014 |
20140059712 | MULTIPLE-VIRUS-RESISTANT MELON - The invention relates to a melon plant, and parts thereof including seeds and fruit, that is resistant to Zucchini Yellow Mosaic Virus (ZYMV) and Watermelon Mosaic Virus (WMV). The melon plant may further comprise resistance to Cucumber Mosaic Virus (CMV) and/or further display a Brix measurement of ≧9.5° Bx, orange flesh color, and/or a fruit width to length ratio of ≧0.5. Methods for producing such a plant are also provided. | 02-27-2014 |
20150376635 | Methods and Compositions for Watermelon Firmness - The invention provides for unique watermelon plants with an ultra-firm flesh phenotype and their progeny. Such plants may comprise an introgressed QTL associated with an ultra-firm flesh phenotype. In certain aspects, compositions, including distinct polymorphic molecular markers, and methods for producing, breeding, identifying, selecting, and the like of plants or germplasm with an ultra-firm flesh phenotype are provided. | 12-31-2015 |
20160029584 | Methods and Compositions for Watermelon with Improved Processing Qualities and Firmness - A watermelon plant that produces fruit having (i) ultra-firm flesh and/or liquid-retaining flesh and (ii) soluble solids of at least about 6 brix. The invention further provides for unique watermelon plants with an ultra-firm flesh phenotype and their progeny. Such plants may comprise an introgressed QTL associated with an ultra-firm flesh phenotype. In certain aspects, compositions, including distinct polymorphic molecular markers, and methods for producing, breeding, identifying, selecting, and the like of plants or germplasm with an ultra-firm flesh phenotype are provided. | 02-04-2016 |
Patent application number | Description | Published |
20110236478 | CO-CRYSTALS AND PHARMACEUTICAL FORMULATIONS COMPRISING THE SAME - An immediate release formulation of an active ingredient. | 09-29-2011 |
20120014912 | PALATABLE PHARMACEUTICAL COMPOSITION - A pharmaceutical formulation comprising:
| 01-19-2012 |
20120064157 | PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF - The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders and mini-tablets and methods for treating cystic fibrosis employing the pharmaceutical composition. | 03-15-2012 |
20130072440 | CO-CRYSTALS AND PHARMACEUTICAL FORMULATIONS COMPRISING THE SAME - The pharmaceutical composition including a co-crystal. The co-crystal includes a) a co-former; and b) an active pharmaceutical ingredient (API) with solubility in water is less than one part by weight of the API in ten parts by weight of water. Furthermore, the formulation includes a polymer, and a weight ratio of the co-crystal to the polymer is about 0.5:99.5 to about 99.5:0.5. The kinetic solubility of the co-crystal after being in contact with an environment of use is at a therapeutically acceptable level for a prolonged period of time. | 03-21-2013 |
20130195797 | HIGH POTENCY FORMULATIONS OF VX-950 - High potency pharmaceutical compositions comprising VX-950, sodium lauryl sulfate and a polymer selected from the group consisting of hypromellose acetate succinate-M, hypromellose acetate succinate-L and hypromellose acetate succinate-H. | 08-01-2013 |
20130224293 | PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF - The present invention relates to pharmaceutical compositions containing a solid dispersion of N—[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition. | 08-29-2013 |
20140255483 | PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF - The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition. | 09-11-2014 |
20150024047 | PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF - The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition. | 01-22-2015 |
20150246031 | PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF - The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition. | 09-03-2015 |
20150320736 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MEDIATED DISEASES - The present invention features compositions comprising a plurality of therapeutic agents wherein the presence of one therapeutic agent enhances the properties of at least one other therapeutic agent. In one embodiment, the therapeutic agents are cystic fibrosis transmembrane conductance regulators (CFTR) such as a CFTR corrector or CFTR potentiator for the treatment of CFTR mediated diseases such as cystic fibrosis. Methods and kits thereof are also disclosed. | 11-12-2015 |
Patent application number | Description | Published |
20100081642 | CB-1 RECEPTOR MODULATOR PHARMACEUTICAL FORMULATIONS - The present invention relates to pharmaceutical compositions that stabilize and improve the bioavailability of 3-[(1S)- 1-(1-{(S)-(4-chlorophenyl)[3-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile. In particular, the present invention relates to pharmaceutical compositions that include 3-[(1S)-1-(1-{(S)-(4-chlorophenyl)[3 -(5-oxo-4,5-dihydro- 1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile and at least one pharmaceutical acceptable excipient, such as a mono-, di- or triglyceride. | 04-01-2010 |
20100209496 | LIQUID AND SEMI-SOLID PHARMACEUTICAL FORMULATIONS FOR ORAL ADMINISTRATION OF A SUBSTITUTED AMIDE - 3-[(3aR,4R,5S,7aS)-5-{(1R)-1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)-octahydro-2H-isoindol-2-yl]cyclopent-2-en-1-one (Compound I) has surprisingly improved solubility, bioavailability and stability in an ampiphilic vehicle that can include propylene glycol, a propylene glycol sparing agent, an antioxidant, or a mixture thereof. In one embodiment of the present invention is a solution comprising the active or a pharmaceutically acceptable salt or solvate thereof, and an amphiphilic agent, said amphiphilic agent being a fatty acid ester of glycerol, propylene glycol or sorbitol. | 08-19-2010 |
Patent application number | Description | Published |
20130064383 | INFORMATION SIGNAL REPRESENTATION USING LAPPED TRANSFORM - An information signal reconstructor is configured to reconstruct, using aliasing cancellation, an information signal from a lapped transform representation of the information signal including, for each of consecutive, overlapping regions of the information signal, a transform of a windowed version of the respective region, wherein the information signal reconstructor is configured to reconstruct the information signal at a sample rate which changes at a border between a preceding region and a succeeding region of the information signal. | 03-14-2013 |
20150332693 | CONCEPT FOR CODING MODE SWITCHING COMPENSATION - A codec allowing for switching between different coding modes is improved by, responsive to a switching instance, performing temporal smoothing and/or blending at a respective transition. | 11-19-2015 |
20150332698 | APPARATUS AND METHOD FOR SELECTING ONE OF A FIRST ENCODING ALGORITHM AND A SECOND ENCODING ALGORITHM - An apparatus for selecting one of a first encoding algorithm having a first characteristic and a second encoding algorithm having a second characteristic for encoding a portion of an audio signal to obtain an encoded version of the portion of the audio signal has a first estimator for estimating a first quality measure for the portion of the audio signal, which is associated with the first encoding algorithm, without actually encoding and decoding the portion of the audio signal using the first encoding algorithm. A second estimator is provided for estimating a second quality measure for the portion of the audio signal, which is associated with the second encoding algorithm, without actually encoding and decoding the portion of the audio signal using the second encoding algorithm. The apparatus has a controller for selecting the first or second encoding algorithms based on a comparison between the first and second quality measures. | 11-19-2015 |
Patent application number | Description | Published |
20090071196 | ELASTIC COMPOSITE YARN, METHODS FOR MAKING THE SAME, AND ARTICLES INCORPORATING THE SAME - An elastic composite yarn comprises a composite core and a composite covering. The composite core comprises an elastic core member and an inelastic functional core member. The composite covering comprises at least an elastic covering member and at least one inelastic covering member surrounding the elastic covering member, such that substantially all of an elongating stress imposed on the composite yarn is carried by the elastic core member and the elastic covering member. | 03-19-2009 |
20090112079 | TEXTILE-BASED ELECTRODE - Textile-based electrodes include a fabric portion having stretch-recovery non-conductive yarns and an electrically conductive region having stretch-recovery electrically conductive yarn filaments. The electrodes can further include float yarns and can be configured in a textured or ribbed construction. When incorporated into a garment, the electrodes can be used to monitor biophysical characteristics, such as the garment wearer's heart rate. | 04-30-2009 |
20090139601 | FUNCTIONAL ELASTIC COMPOSITE YARN, METHODS FOR MAKING THE SAME AND ARTICLES INCORPORATING THE SAME - A functional elastic composite yarn comprises an elastic member that is surrounded by at least one functional covering filament(s). The functional covering filament has a length that is greater than the drafted length of the elastic member such that substantially all of an elongating stress imposed on the composite yarn is carried by the elastic member. The elastic composite yarn may further include an optional stress-bearing member surrounding the elastic member and the functional covering filament. | 06-04-2009 |
20090145533 | ELECTRICALLY CONDUCTIVE ELASTIC COMPOSITE YARN, METHODS FOR MAKING THE SAME, AND ARTICLES INCORPORATING THE SAME - An electrically conductive elastic composite yarn comprises an elastic member that is surrounded by at least one conductive covering filament(s). The elastic member has a predetermined relaxed unit length L and a predetermined drafted length of (N×L), where N is a number preferably in the range from about 1.0 to about 8.0. The conductive covering filament has a length that is greater than the drafted length of the elastic member such that substantially all of an elongating stress imposed on the composite yarn is carried by the elastic member. The elastic composite yarn may further include an optional stress-bearing member surrounding the elastic member and the conductive covering filament. The length of the stress-bearing member is less than the length of the conductive covering filament and greater than, or equal to, the drafted length (N×L) of the elastic member, such that a portion of the elongating stress imposed on the composite yarn is carried by the stress-bearing member. | 06-11-2009 |
20090159149 | SURFACE FUNCTIONAL ELECTRO-TEXTILE WITH FUNCTIONALITY MODULATION CAPABILITY, METHODS FOR MAKING THE SAME, AND APPLICATIONS INCORPORATING THE SAME - A surface functional electro-textile fabric incorporates energy-active, electrically conductive or optically conductive fibers and nonconductive fibers in a woven or knitted textile fabric. The weave or knit pattern is selected so as to form floats of the electrically conductive fibers on at least one surface of the electro-textile fabric. The electro-textile fabric can be incorporated into an antenna structure that interacts with high frequency electromagnetic radiation, particularly in the frequency range of DC to 100 GHz. | 06-25-2009 |
20090176091 | Flame retardant thermoplastic elastomer compositions - Flame retardant thermoplastic elastomer composition comprising a thermoplastic vulcanizate composition and non-halogenated flame retardant. | 07-09-2009 |
20100230203 | Energy Absorbing Thermoplastic Elastomer - The present invention relates to a method for vibration damping and noise reduction by using thermoplastic vulcanizate compositions and to multilayer structures for use in vibration damping and noise reduction applications comprising at least one polymeric layer made of a thermoplastic vulcanizate composition. | 09-16-2010 |
20110288394 | TEXTILE-BASED ELECTRODE - Textile-based electrodes include a fabric portion having stretch-recovery non-conductive yarns and an electrically conductive region having stretch-recovery electrically conductive yarn filaments. The electrodes can further include float yarns and can be configured in a textured or ribbed construction. When incorporated into a garment, the electrodes can be used to monitor biophysical characteristics, such as the garment wearer's heart rate. In addition, two garments with textile based electrodes are disclosed. First, a wrist band for use with a cardiac patient remote monitoring system includes two fabric layers with integral textile-based electrodes. The skin contacting surface of the band includes a conductive region formed as a continuous ring or stripe. A connector links the conductive region to a lead to a device. Second, an infant garment includes textile based electrodes at the torso region and optionally at other regions in order to monitor the infant's biophysical characteristics as the garment is worn. | 11-24-2011 |
20120211256 | HEAT STABLE HALOGEN-FREE FLAME RETARDANT COPOLYESTER THERMOPLASTIC ELASTOMER COMPOSITIONS - Halogen-free flame retardant compositions exhibiting flame retardance and retention of mechanical properties, especially elongation at break, upon long-term high temperature exposure and comprising a) at least one copolyester thermoplastic elastomer, and b) from at or about 1 to at or about 30 weight percent, based on the total weight of the composition, of at least one flame retardant comprising a phosphinate, diphosphinate and/or polymers of these; c) from at or about 0.25 to at or about 15 weight percent, based on the total weight of the flame retardant composition, of one or more polyhydroxy polymers having a number average molecular weight of at least 2000 and selected from the group consisting of ethylene vinyl alcohol copolymers and poly(vinyl alcohol)s. | 08-23-2012 |
20120224818 | LOW SMOKE HALOGEN FREE FLAME RETARDANT THERMOPLASTIC ELASTOMER COMPOSITIONS CONTAINING ZEOLITES - Halogen-free flame retardant compositions comprising thermoplastic elastomers, which exhibit flame retardance and low-smoke emission. The flame retardant compositions comprise a) one or more thermoplastic elastomers, and b) from at or about 18 to at or about 50 weight percent, the weight percentage being based on the total weight of the flame retardant composition, of a flame retardant mixture comprising: b1) at least one flame retardant comprising a phosphinate, diphosphinate and/or polymers thereof, b2) a phosphorous-containing amino composition; and b3) a zeolite. | 09-06-2012 |
20120225291 | LOW SMOKE HALOGEN FREE FLAME RETARDANT THERMOPLASTIC VULCANIZATE COMPOSITIONS CONTAINING ZEOLITES - Halogen-free flame retardant compositions comprising thermoplastic vulcanizates, which exhibit desired flame retardance and low-smoke emission. These flame retardant compositions comprise a) one or more thermoplastic vulcanizates, and b) from at or about 18 to at or about 50 weight percent, the weight percentage being based on the total weight of the flame retardant composition, of a flame retardant mixture comprising: b1) at least one flame retardant comprising a phosphinate, diphosphinate and/or polymers thereof, b2) a phosphorous-containing amino composition, and b3) a zeolite. | 09-06-2012 |
20130327558 | HALOGEN FREE FLAME RETARDANT THERMOPLASTIC ELASTOMER COMPOSITIONS HAVING IMPROVED INSULATION RESISTANCE - Halogen-free flame retardant compositions comprising copolyetherester thermoplastic elastomers, melamine cyanurate and epoxy-containing compounds and cables and wires made from such flame retardant polymer composition provide good electrical insulation resistance during use. | 12-12-2013 |
20160108232 | ABRASION RESISTANT AND FLAME RETARDANT THERMOPLASTIC VULCANIZATE COMPOSITIONS - The present invention relates to flame retardant thermoplastic vulcanizate compositions having improved abrasion resistance and strip force. In addition, the invention relates to wire and cable coated with these compositions. The flame retardant thermoplastic vulcanizate compositions comprise a thermoplastic vulcanizate composition, at least one halogen-free flame retardant and an ultra-high molecular weight polysiloxane. | 04-21-2016 |